Editorial Commentary: Stem Cell Therapy for the Knee: Heterogeneity in Cell Sources, Delivery Methods, and Concomitant Surgery Needs to Be Considered

Citations

WEB OF SCIENCE

1
Citations

SCOPUS

1

초록

Mesenchymal stem cells (MSCs) have been investigated for the treatment of knee osteoarthritis because of their unique properties, including self-renewal, multi-linear cellular differentiation, and immunomodulatory capacity. However, the efficacy of MSCs for positive clinical outcomes in the treatment of knee osteoarthritis remains controversial. Because clinical studies in general have high variability, the heterogeneity in the sources of the stem cells used, efficacy of delivery methods, and concomitant surgery should be carefully considered to interpret the benefits of MSC therapy for knee osteoarthritis. © 2020 Arthroscopy Association of North America

제목
Editorial Commentary: Stem Cell Therapy for the Knee: Heterogeneity in Cell Sources, Delivery Methods, and Concomitant Surgery Needs to Be Considered
저자
Park, Y.-B.
DOI
10.1016/j.arthro.2020.07.035
발행일
2021-01
유형
Editorial Material
저널명
Arthroscopy - Journal of Arthroscopic and Related Surgery
권
37
호
1
페이지
379 ~ 380